1. Home
  2. HITI vs ORGO Comparison

HITI vs ORGO Comparison

Compare HITI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.53

Market Cap

220.6M

Sector

N/A

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.49

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
ORGO
Founded
2009
1985
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.6M
239.3M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
HITI
ORGO
Price
$2.53
$1.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.13
$8.50
AVG Volume (30 Days)
481.2K
638.3K
Earning Date
06-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
$23.73
N/A
Revenue Next Year
$12.80
$26.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.04
52 Week Low
$2.02
$1.54
52 Week High
$4.06
$7.08

Technical Indicators

Market Signals
Indicator
HITI
ORGO
Relative Strength Index (RSI) 58.64 30.07
Support Level $2.35 N/A
Resistance Level $2.60 $2.58
Average True Range (ATR) 0.08 0.09
MACD 0.00 0.00
Stochastic Oscillator 49.12 0.00

Price Performance

Historical Comparison
HITI
ORGO

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: